Corporate Overview for Investors
Fytokem’s ongoing commitment to our stakeholders is to develop our commercial activities at the optimal sustainable rate with an interest in maximizing the Company’s potential and thereby increasing shareholder value.
Fytokem is publicly-traded on the TSX Venture Exchange under the symbol FYT.
Growth Strategy
The Company’s strategy is to leverage its core technologies through strategic partnerships with experts in the marketing and distribution of products in our four major industries. These companies provide product identification, industry intelligence, marketing expertise and distribution channels for our products. Revenue generated from sales is put toward research and development of new products, notably high-end bio-active molecules from naturally occurring sources.
Investment Highlights
- The Company has existing products and revenues
- The Company has a global distribution system already in place.
- Personal Care — Atrium Biotechnologies Inc.
- Nutraceuticals — Atrium Biotechnologies Inc.
- Bio-Industrial — Lonza Inc.
- Enthusiastic response from major brand name companies/customers
- The markets targeted are very large and well established.
- The Company is capitalizing on the strong market shift from synthetic, animal and mineral-based products to plant-based products.
- The Company utilizes fresh, pure and natural plant materials grown under extreme environmental conditions. These highly potent plant materials have developed strong phytochemical properties to survive the harsh climate.
